The page is the record's research on the issuer — no analyst, no rating, no view. # Eikon Therapeutics, Inc. (NASDAQ: EIKN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Eikon Therapeutics, Inc., listed on NASDAQ under ticker EIKN, with ISIN US2825641036. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 60 filings in the twelve months to 2026-11-08, on 31 filing days. Of these, 28 are directors' dealings, 15 are regulatory filings, 6 are results, 4 are prospectuses, 4 are corporate news, 2 are director changes, and 1 is ad hoc. The median gap between filing days is 5.0 days. The latest filing is dated 2026-10-26 and is of type corporate news, 13 days before the record date. The NASDAQ peer median is 6.0 days for cadence gap, 52 filings and 5.0 days of latency across 4,359 issuers. The sector peer median is 5.5 days for cadence gap, 65.5 filings and 4.0 days of latency across 176 issuers. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover; foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds listing lines dated 2026-01-28 and 2026-02-04. It holds no delisting and no name change. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed in the record are 2021, 2022, 2023, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. The market's vintage is sealed. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001861123.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/EIKN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/EIKN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/EIKN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp